尿酸和血清胱抑素C对高血压肾损害早期诊断的预测价值
Prediction of Renal Damage Complicated by Hypertension With Uric Acid and Serum Cystatin C as Early Marker
摘要:
目的: 探讨血尿酸和血清胱抑素C对高血压肾损害的早期诊断价值。方法: 前瞻性纳入我院收治的原发性高血压患者151例。根据是否并发肾损害,将患者分为单纯高血压组(I组)和高血压肾损害组(Ⅱ组),采用全自动生化分析仪同时测定血清尿酸、肌酐和尿素氮,免疫透射比浊法测定血清胱抑素C含量,并与健康体检者(对照组)相关指标作对比研究,并进行相关分析,评价血尿酸和血清胱抑素C对高血压肾损害早期诊断的价值。结果:I组、Ⅱ组血尿酸和血清胱抑素C的阳性率明显高于对照组(P < 0.01)。同组患者血尿酸和血清胱抑素C的阳性率明显高于其血尿素和血肌酐阳性率(P < 0.01)。此外,高血压患者血尿酸和血清胱抑素C的升高早于血尿素和血肌酐。结论: 血尿酸和血清胱抑素C是反映高血压早期肾功能损害的敏感指标,其敏感度高于血尿素和血肌酐,在诊断高血压早期肾损害方面有重要的临床价值。
>Abstract: Objective: To determine whether blood uric acid and serum cystatin C were early biomarkers of renal dam- age secondary to hypertension. Methods: A total of 151 eligible patients were enrolled in this prospective study. Ac- cording to the rate of kidney damage, the patients were divided into hypertension group (group I) and hyper-tensive renal injury group (groupⅡ). The concentrations of blood uric acid, creatinine and urea nitrogen were measured by automatic chemistry analysis and the concentration of serum cystatin C was measured by immune transmission nephelometry. The results were compared with those in control group and the evaluation was etrospectively analyzed. Results: The blood uric acid and serum cystatin C-positive rates of group I and groupⅡwere significantly higher than those of the control group (P < 0.01). However, the blood uric acid and serum cystatin C-positive rates in hypertensive patients were significantly higher than the blood urea and serum creatinine-positive rates (P < 0.01). In addition, the blood uric acid and serum cystatin C in hypertensive patients increased far earlier than blood urea and serum creatinine did. Conclusion: The blood uric acid and serum cystatin C are the sensitive indicators of hypertension with early renal damage. The sensitivity of blood uric acid and serum cystatin C is higher than that of the blood urea and serum creatinine. Therefore, detection of blood uric acid and serum cystatin C level has important clinical value in the diagnosis of hypertension with early renal damage.
参考文献
[1]
|
Bagshaw, S.W. and Gibney, R.T. (2008) Conventional markers of kidney function. Crit Care Med, 36, S152-S158.
|
[2]
|
陆再英, 钟南山, 主编 (2008) 内科学. 北京人民卫生出版社, 北京, 51-262.
|
[3]
|
Mule, G., Cottone, S., Nardi, E., et a1. (2006) Metabolic syndrome in subjects with essential hypertension: Relationships with subclinical cardiovascular and renal damage. Minerva Car- dioangiologica, 54, 173-194.
|
[4]
|
Talaat, K.M. and EI-Sheikh, A.R. (2007) The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. American Journal of Nephrology, 27, 435-440.
|
[5]
|
Convento, M.S., Pesson, E., Dalboni, M.A., et al. (2011) pro- inflammatory and oxidative effect of noncrystalline uric acid in human mesangial cells: Contribution to hyperuricemic glomerular damage. Urological Research, 39, 21-27.
|
[6]
|
Qian, Q., Kassem, K.M., Beierwaltes, W.H., et al. (2009) PGE2 causes mesangial cell hypertrophy and decreases expression of cyclin D3. Nephron Physiology, 113, 7-14.
|
[7]
|
Luc, G., Bard, J.M. and Lesueur, C. (2006) Plasma cystatin-C and development of Coro-nary heart disease: The PRIME Study. Atherosclerosis, 18, 375-380.
|
[8]
|
Bokenkamp, A., Herget-Rosenthal, S., Bokenkamp, R. and Cystatin, C. (2006) kidney function and cardiovascular rdisease. Pediatric Nephrology, 21, 1223-1230.
|
[9]
|
Madero, M., Sarnak, M.J. and Stevens, L.A. (2006) Serum cystatin C as a marker of glomerular filtrationrate. Current Opinion in Nephrology and Hypertension, 15, 610-616.
|